Hematologic Oncology Update
Episodes
Meet The Professor: Optimizing the Management of Myelofibrosis — Part 1 of a 2-Part Series
08 Mar 2024
Contributed by Lukas
Dr Stephen T Oh from Washington University School of Medicine in St Louis, Missouri, discusses current and emerging monitoring and management strategi...
Year in Review: Clinical Investigator Perspectives on the Most Relevant New Data Sets and Advances in Chronic Lymphocytic Leukemia
27 Feb 2024
Contributed by Lukas
Dr Lindsey Roeker from Memorial Sloan Kettering Cancer Center in New York, New York, and Dr Jeff Sharman of the US Oncology Network in Eugene, Oregon,...
Meet The Professor: Optimizing the Management of Acute Myeloid Leukemia and Myelodysplastic Syndromes — Part 3 of a 3-Part Series
17 Jan 2024
Contributed by Lukas
Dr Richard M Stone from Dana-Farber Cancer Institute in Boston discusses the optimal selection and sequencing of systemic therapies for patients with ...
Meet The Professor: Optimizing the Management of Acute Myeloid Leukemia and Myelodysplastic Syndromes — Part 2 of a 3-Part Series
10 Nov 2023
Contributed by Lukas
Dr Gail J Roboz from Weill Cornell Medicine in New York discusses the optimal management of acute myeloid leukemia and myelodysplastic syndromes.
Meet The Professor: Optimizing the Management of Acute Myeloid Leukemia and Myelodysplastic Syndromes — Part 1 of a 3-Part Series
20 Oct 2023
Contributed by Lukas
Dr Naval Daver from The University of Texas MD Anderson Cancer Center in Houston, Texas, discusses current and emerging optimal management approaches ...
What Clinicians Want to Know About the Management of Relapsed/Refractory Mantle Cell Lymphoma
19 Oct 2023
Contributed by Lukas
Dr Toby A Eyre from the Oxford University Hospitals NHS Foundation Trust in Oxford, United Kingdom, and Dr Brad S Kahl from Siteman Cancer Center in S...
Oncology Today with Dr Neil Love: Key Presentations on Multiple Myeloma from Recent Major Oncology/Hematology Conferences
18 Oct 2023
Contributed by Lukas
Dr Joseph Mikhael from the City of Hope Cancer Center in Phoenix, Arizona, discusses recent updates and future directions in the management of newly d...
Oncology Today with Dr Neil Love: Bispecific Antibodies in the Management of Non-Hodgkin Lymphoma with Dr Matthew Matasar
12 Oct 2023
Contributed by Lukas
Dr Matthew Matasar from the Rutgers Cancer Institute of New Jersey in New York, New York, discusses the current and future role of CD20 x CD3 bispec...
What Clinicians Want to Know About Anti-CD38 Antibodies in the Management of Multiple Myeloma
09 Oct 2023
Contributed by Lukas
Prof Philippe Moreau from the University Hospital of Nantes in France discusses anti-CD38 antibody-based treatment approaches for newly diagnosed and ...
Oncology Today with Dr Neil Love: Blastic Plasmacytoid Dendritic Cell Neoplasm
05 Oct 2023
Contributed by Lukas
Dr Naveen Pemmaraju from the University of Texas MD Anderson Cancer Center in Houston, Texas, discusses current and emerging management approaches for...
Oncology Today with Dr Neil Love: Emerging Role of CELMoDs (Cereblon E3 Ligase Modulators) and Other Novel Approaches to Targeting Protein Degradation Pathways in Multiple Myeloma
28 Sep 2023
Contributed by Lukas
Dr Paul G Richardson from Dana-Farber Cancer Institute in Boston discusses the emerging role of CELMoDs and other novel approaches to targeting protei...
What Clinicians Want to Know About Toxicity Considerations Associated with BTK Inhibitors
22 Sep 2023
Contributed by Lukas
Dr Nicole Lamanna from the Columbia University Herbert Irving Comprehensive Cancer Center in New York, New York, and Dr William G Wierda from The Univ...
Inside the Issue: The Current and Future Role of CD20 x CD3 Bispecific Antibodies in the Management of Non-Hodgkin Lymphoma
14 Sep 2023
Contributed by Lukas
Dr Martin Hutchings from Rigshospitalet, Copenhagen University Hospital in Copenhagen, Denmark, and Dr Loretta Nastoupil from The University of Texas ...
Oncology Today with Dr Neil Love: Role of BTK Inhibitors in Patients with Mantle Cell Lymphoma
31 Aug 2023
Contributed by Lukas
Featuring a discussion on BTK inhibitors for the management of mantle cell lymphoma with Dr Michael Wang, moderated by Dr Neil Love.
Meet The Professor: Optimizing the Management of Soft Tissue Sarcoma and Related Connective Tissue Disorders — Part 2 of a 2-Part Series
30 Aug 2023
Contributed by Lukas
Dr Richard F Riedel from Duke Cancer Institute in Durham, North Carolina, discusses approved and novel treatment approaches for soft tissue sarcoma, m...
Oncology Today with Dr Neil Love: Special Edition — Key Presentations on Chronic Lymphocytic Leukemia and Lymphoma from Recent Major Oncology/Hematology Conferences
29 Aug 2023
Contributed by Lukas
Dr Jeremy Abramson from Massachusetts General Hospital in Boston discusses key presentations on chronic lymphocytic leukemia and lymphomas from recent...
Inside the Issue: Integrating Bispecific Antibodies into the Management of Multiple Myeloma — Patient Selection and Toxicity Management
23 Aug 2023
Contributed by Lukas
Dr Hans Lee from The University of Texas MD Anderson Cancer Center in Houston, Texas, and Dr Saad Zafar Usmani from Memorial Sloan Kettering Cancer Ce...
Oncology Today with Dr Neil Love: Special Edition — What I Tell My Patients About New Treatments and Clinical Trials in Chronic Lymphocytic Leukemia
18 Aug 2023
Contributed by Lukas
Dr Kerry Rogers from the Ohio State University in Columbus, Ohio, discusses the education and care of patients with chronic lymphocytic leukemia
Inside the Issue: Novel Agents, Approaches and Strategies in the Management of Higher-Risk Myelodysplastic Syndromes
02 Aug 2023
Contributed by Lukas
Featuring perspectives from Dr Guillermo Garcia-Manero and Dr David Sallman, moderated by Dr Neil Love.
Oncology Today with Dr Neil Love: Immune Thrombocytopenia Edition
31 Jul 2023
Contributed by Lukas
Dr Hanny Al-Samkari from Harvard Medical School in Boston, Massachusetts, discusses the presentation and management of immune thrombocytopenia.
Oncology Today with Dr Neil Love: Management of Paroxysmal Nocturnal Hemoglobinuria
26 Jul 2023
Contributed by Lukas
Featuring a discussion on the biology and treatment of paroxysmal nocturnal hemoglobinuria with Dr Carlos de Castro, moderated by Dr Neil Love.
Meet The Professor: The Current and Future Management of Non-Hodgkin Lymphoma
10 Jul 2023
Contributed by Lukas
Featuring a discussion on the management of non-Hodgkin lymphoma with Dr Ian W Flinn, moderated by Dr Neil Love.
Meet The Professor: Optimizing the Management of Soft Tissue Sarcoma and Related Connective Tissue Disorders — Part 1 of a 2-Part Series
16 Jun 2023
Contributed by Lukas
Featuring a discussion on the management of soft tissue sarcoma and related connective tissue disorders with Dr Brian Van Tine, moderated by Dr Neil L...
Year in Review: Clinical Investigator Perspectives on the Most Relevant New Data Sets and Advances in Acute Myeloid Leukemia and Myelodysplastic Syndromes
21 Apr 2023
Contributed by Lukas
Proceedings from our Year in Review webinar on the management of acute myeloid leukemia and myelodysplastic syndromes. Featuring perspectives from Dr ...
Oncology Today with Dr Neil Love: Key Presentations from the 64th American Society of Hematology (ASH) Annual Meeting: Multiple Myeloma Edition
19 Apr 2023
Contributed by Lukas
Featuring a discussion on newly presented data in multiple myeloma from the 2022 ASH Annual Meeting, with Dr Jacob Laubach, moderated by Dr Neil Love.
Oncology Today with Dr Neil Love — Key Presentations from the 64th American Society of Hematology (ASH) Annual Meeting: Chronic Lymphocytic Leukemia Edition
12 Apr 2023
Contributed by Lukas
Featuring a discussion on chronic lymphocytic leukemia studies presented at ASH 2022 with Dr John Allan, moderated by Dr Neil Love.
Recent Advances and Future Directions in Chronic Lymphocytic Leukemia and Lymphomas — With Dr Danielle Brander and Craig Moskowitz (Proceedings from a Symposium in Partnership with NCOA and SCOS)
17 Mar 2023
Contributed by Lukas
Proceedings from a daylong symposium hosted in partnership with North Carolina Oncology Association and the South Carolina Oncology Society, featuring...
Oncology Today with Dr Neil Love: Key Presentations in Hodgkin and Non-Hodgkin Lymphomas from the 2022 ASH Annual Meeting
02 Mar 2023
Contributed by Lukas
Featuring a discussion on lymphoma studies presented at ASH 2022, with Dr Matthew Lunning, moderated by Dr Neil Love.
Inside the Issue — Optimizing the Management of Adverse Events Associated with BTK Inhibitors
23 Feb 2023
Contributed by Lukas
Proceedings from a webinar on optimizing the management of adverse events associated with BTK inhibitors with Drs Farrukh Awan and Kerry Rogers, moder...
Year in Review: Clinical Investigator Perspectives on the Most Relevant New Data Sets and Advances in Hodgkin and Non-Hodgkin Lymphomas
17 Feb 2023
Contributed by Lukas
Proceedings from our Year in Review webinar on the management of lymphomas. Featuring perspectives from Drs Christopher Flowers and Laurie Sehn, moder...
Meet The Professor: Optimizing the Management of Multiple Myeloma — Part 4 of a 4-Part Series
14 Feb 2023
Contributed by Lukas
Featuring a discussion on the treatment of multiple myeloma with Dr Noopur Raje, moderated by Dr Neil Love.
Oncology Today with Dr Neil Love: Key Presentations on Myeloproliferative Neoplasms from the 2022 ASH Annual Meeting
09 Feb 2023
Contributed by Lukas
Featuring a discussion on newly presented data with myelofibrosis, polycythemia vera and essential thrombocythemia with Dr Srdan Verstovsek, moderated...
Oncology Today with Dr Neil Love: Advances in Diffuse Large B-Cell Lymphoma
06 Feb 2023
Contributed by Lukas
Featuring a discussion on recent data with targeted therapies for the treatment of diffuse large B-cell lymphoma with Dr Gilles Salles, moderated by D...
Oncology Today with Dr Neil Love: Key Presentations in Acute Myeloid Leukemia and Myelodysplastic Syndromes from the 2022 ASH Annual Meeting
02 Feb 2023
Contributed by Lukas
Featuring a discussion on newly presented data in acute myeloid leukemia and myelodysplastic syndromes from the 2022 ASH Annual Meeting with Dr Richar...
Year in Review: Clinical Investigator Perspectives on the Most Relevant New Data Sets and Advances in Multiple Myeloma
01 Feb 2023
Contributed by Lukas
Proceedings from our Year in Review webinar on the management of multiple myeloma. Featuring perspectives from Drs Joseph Mikhael and Ajay Nooka, mode...
Year in Review: Clinical Investigator Perspectives on the Most Relevant New Data Sets and Advances in Chronic Lymphocytic Leukemia
20 Jan 2023
Contributed by Lukas
Proceedings from our Year in Review webinar on the management of chronic lymphocytic leukemia. Featuring perspectives from Drs Jennifer Brown and Debo...
Meet The Professor: Optimizing the Management of Multiple Myeloma — Part 3 of a 4-Part Series
19 Jan 2023
Contributed by Lukas
Featuring a discussion on the treatment of multiple myeloma with Dr Shaji Kumar, moderated by Dr Neil Love.
What Clinicians Want to Know: Addressing Current Questions and Controversies in the Management of Acute Myeloid Leukemia
13 Jan 2023
Contributed by Lukas
Featuring perspectives from Drs Courtney DiNardo and Mark Levis, moderated by Dr Neil Love.